Zoe Diana Draelos1. 1. Department of Dermatology, Duke University School of Medicine, Durham, North Carolina. Electronic address: zdraelos@northstate.net.
Abstract
BACKGROUND:Lignin peroxidase is a cosmetic skin-lightening alternative that breaks down plant cell walls and melanin. OBJECTIVE: This research examined the topical efficacy of lignin peroxidase in pigment lightening. METHODS:Sixty women aged 18 to 65 years with mild to moderate facial dyspigmentation were enrolled for 12 weeks in 2 cohorts. Cohort 1 applied lignin peroxidase to 1 randomized side of the face and nothing to the opposite side. Cohort 2 applied lignin peroxidase to 1 facial side and generic hydroquinone to the other. Investigator, subject, and dermospectrophotometer measurements were obtained. RESULTS: In cohort 1, improved skin texture (P < .001), roughness (P < .001), and overall appearance (P = .002) was noted at week 2 with lignin peroxidase versus no treatment. By week 12, there was a decrease in spot size with lignin peroxidase versus no treatment (P = .014). This was confirmed by a statistically significant reduction in melanin scores with the dermospectrophotometer on lignin peroxidase-treated side at weeks 4, 8, and 12 (P = .003) and a similar reduction in Melasma Area Severity Index score. Cohort 2 demonstrated parity between lignin peroxidase and hydroquinone, but lignin peroxidase was statistically superior in skin texture and roughness. LIMITATIONS: The sample size was limited. CONCLUSIONS:Lignin peroxidase might be an over-the-counter skin-lightening preparation with efficacy parity to hydroquinone.
RCT Entities:
BACKGROUND:Lignin peroxidase is a cosmetic skin-lightening alternative that breaks down plant cell walls and melanin. OBJECTIVE: This research examined the topical efficacy of lignin peroxidase in pigment lightening. METHODS: Sixty women aged 18 to 65 years with mild to moderate facial dyspigmentation were enrolled for 12 weeks in 2 cohorts. Cohort 1 applied lignin peroxidase to 1 randomized side of the face and nothing to the opposite side. Cohort 2 applied lignin peroxidase to 1 facial side and generic hydroquinone to the other. Investigator, subject, and dermospectrophotometer measurements were obtained. RESULTS: In cohort 1, improved skin texture (P < .001), roughness (P < .001), and overall appearance (P = .002) was noted at week 2 with lignin peroxidase versus no treatment. By week 12, there was a decrease in spot size with lignin peroxidase versus no treatment (P = .014). This was confirmed by a statistically significant reduction in melanin scores with the dermospectrophotometer on lignin peroxidase-treated side at weeks 4, 8, and 12 (P = .003) and a similar reduction in Melasma Area Severity Index score. Cohort 2 demonstrated parity between lignin peroxidase and hydroquinone, but lignin peroxidase was statistically superior in skin texture and roughness. LIMITATIONS: The sample size was limited. CONCLUSIONS:Lignin peroxidase might be an over-the-counter skin-lightening preparation with efficacy parity to hydroquinone.
Authors: Ayodeji O Falade; Uchechukwu U Nwodo; Benson C Iweriebor; Ezekiel Green; Leonard V Mabinya; Anthony I Okoh Journal: Microbiologyopen Date: 2016-09-07 Impact factor: 3.139
Authors: Ayodeji O Falade; Onyedikachi A L Eyisi; Leonard V Mabinya; Uchechukwu U Nwodo; Anthony I Okoh Journal: Biotechnol Rep (Amst) Date: 2017-10-10